A time to meet new and difficult challenges
22 March, 2005 by Bob WilliamsonBob Williamson calls on long experience to express hopes for the future.
Future human capital
22 March, 2005 by Fiona StanleyPrevention and prevention strategies form the basis of a coordinated path for the future of child healthcare, writes Fiona Stanley.
View from the future
22 March, 2005 by Simon EastealSimon Easteal and Pythia Demonsthenes step back from 2050 to brief us on a century of healthcare.
Interview: In Darwin's wake
22 March, 2005 by Melissa TrudingerHe revolutionised the human genome project. Now, Craig Venter is hoping to do the same for our understanding of the rest of the planet. Melissa Trudinger caught up with himon the Australian leg of his voyage of discovery on his yacht, Sorcerer II.
Interview: Still stealing the spotlight
22 March, 2005 by Susan WilliamsonAt 72, you'd think angiogenesis pioneer Judah Folkman would have the grace to slow down a little. Not so, finds Susan Williamson.
Science media centre planned for Adelaide
21 March, 2005 by Graeme O'NeillAt the suggestion of eminent UK neuroscience researcher Baroness Susan Greenfield, the South Australian Government is establishing an Australian Science Media Centre (AusSMC) in Adelaide to serve as a national portal for the media to obtain expert advice on science subjects.
Sarbanes-Oxley weighs heavy on biotechs
18 March, 2005 by Melissa TrudingerAustralian companies contemplating a listing on Nasdaq have a new set of regulatory concerns to consider, with the introduction of the controversial Sarbanes-Oxley legislation in the US.
IBM's Kovac welcomes age of information-based medicine
15 March, 2005 by Melissa TrudingerThere are tremendous opportunities in personalised or information-based medicine, according to Carol Kovac, IBM's general manager for life sciences and healthcare. Kovac has come to Australia as a visiting international fellow for the InnovationXchange Network.
Protemix founder named NZ's 'biotechnologist of the year'
15 March, 2005 by Iain ScottProf Garth Cooper, the president and chief scientist of Auckland-based Protemix, has been named NZBio's 'distinguished biotechnologist of the year' at the New Zealand biotech organisation's conference.
Polartechnics cancels EGM
11 March, 2005 by Renate KrelleRichard Opara has withdrawn his request for a extraordinary general meeting at Sydney device company Polartechnics (ASX:PLT), the company announced today.
In brief: Cytopia; LCT; Rockeby
10 March, 2005 by Staff WritersCytopia (ASX:CYT) today filed an Investigational New Drug Application with the US Food and Drug Administration, seeking approval to test its cancer drug candidate CYT997 in the clinic.
I want what's best for Australian biotech, says Opara
09 March, 2005 by Renate KrelleAs a new self-designated "shaker" of the Australian biotechnology sector, Polish-born medico and property investor Richard Opara is almost rueful about the two board spills he is orchestrating at Australian Cancer Technologies (ASX:ACU) and Polartechnics (ASX:PLT). But he is adamant that there is "no substance" to the speculation that the companies will merge.
Chemeq company secretary steps down
09 March, 2005 by Melissa TrudingerChemeq's (ASX:CMQ) company secretary Adam Deane has advised the company that he intends to step down. He is the third person from the company's executive team to leave since mid-December.
February a cruel month for biotech
08 March, 2005 by Staff WritersBiotechnology stocks fell 7 per cent in February, dropping below their August 2003 levels, according to stockbroker Intersuisse.
Chemeq says it will meet production requirements
08 March, 2005 by Melissa TrudingerChemeq (ASX:CMQ) has clarified its current and future production capabilities after questions were raised in a research report about the ability of the company to produce the levels of product required by new investment partner Mizuho.
